Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Graziani, A; Rosker, C; Kohlwein, SD; Zhu, MX; Romanin, C; Sattler, W; Groschner, K; Poteser, M.
Cellular cholesterol controls TRPC3 function: evidence from a novel dominant-negative knockdown strategy.
Biochem J. 2006; 396(1): 147-155. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Autor/innen der Med Uni Graz:
Groschner Klaus
Poteser Michael
Rosker Christian
Sattler Wolfgang
Altmetrics:

Dimensions Citations:

Plum Analytics:
Number of Figures: 6
| | | | | |
Abstract:
TRPC3 (canonical transient receptor potential protein 3) has been suggested to be a component of cation channel complexes that are targeted to cholesterol-rich lipid membrane microdomains. In the present study, we investigated the potential role of membrane cholesterol as a regulator of cellular TRPC3 conductances. Functional experiments demonstrated that cholesterol loading activates a non-selective cation conductance and a Ca2+ entry pathway in TRPC3-overexpressing cells but not in wild-type HEK-293 (human embryonic kidney 293) cells. The cholesterol-induced membrane conductance exhibited a current-to-voltage relationship similar to that observed upon PLC (phospholipase C)-dependent activation of TRPC3 channels. Nonetheless, the cholesterol-activated conductance lacked negative modulation by extracellular Ca2+, a typical feature of agonist-activated TRPC3 currents. Involvement of TRPC3 in the cholesterol-dependent membrane conductance was further corroborated by a novel dominant-negative strategy for selective blockade of TRPC3 channel activity. Expression of a TRPC3 mutant, which contained a haemagglutinin epitope tag in the second extracellular loop, conferred antibody sensitivity to both the classical PLC-activated as well as the cholesterol-activated conductance in TRPC3-expressing cells. Moreover, cholesterol loading as well as PLC stimulation was found to increase surface expression of TRPC3. Promotion of TRPC3 membrane expression by cholesterol was persistent over 30 min, while PLC-mediated enhancement of plasma membrane expression of TRPC3 was transient in nature. We suggest the cholesterol content of the plasma membrane as a determinant of cellular TRPC3 activity and provide evidence for cholesterol dependence of TRPC3 surface expression.
Find related publications in this database (using NLM MeSH Indexing)
Calcium Signaling -
Carbachol - pharmacology
Cations - metabolism
Cell Line -
Cholesterol - physiology
Epitopes - genetics
Gene Targeting -
Genes, Dominant -
Genes, Reporter -
Humans -
Ion Transport - drug effects
Kidney - cytology
Membrane Lipids - physiology
Mutagenesis, Insertional -
Patch-Clamp Techniques -
Recombinant Fusion Proteins - physiology
TRPC Cation Channels - genetics TRPC Cation Channels - physiology
Transfection -
beta-Cyclodextrins - pharmacology

Find related publications in this database (Keywords)
canonical transient receptor potential protein 3 (TRPC3)
Ca2+ signalling
dominant-negative knockdown
lipid microdomain
membrane cholesterol
non-selective cation channel
© Med Uni Graz Impressum